A/Prof Dominic Wall
Interim Chief Executive Officer, Chief Scientific Officer
Dominic oversees the quality and production nominees for the purposes of licensing by the Therapeutic Goods Administration (TGA).
At the Peter MacCallum Cancer Centre, Dominic has a joint appointment as the Executive Director for Business Ventures, leading its enterprises such as the external Pathology services. He also provides executive oversight to the national Centre of Excellence in Cellular Immunotherapy which was established in 2019 with an $80 million contribution from the Commonwealth Government.
Dominic’s academic background and interests are primarily in cancer immunotherapy, in vivo cell tracking in human cell therapy (using nuclear medicine and MRI) and regulation of the developing cell and gene therapy field. He has published more than 80 manuscripts, abstracts and presentations in these areas, and has previously been the ANZ regional president of the International Society for Cell & Gene Therapy (ISCT).
In 1999 Dominic developed the cell therapy program at Peter Mac and was one of the founders of Cell Therapies in 2003, leading it to becoming the first TGA licensed service in this field in Australia.